We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$26B
AUM Growth
+$2.52B
Cap. Flow
+$734M
Cap. Flow %
2.83%
Top 10 Hldgs %
21.08%
Holding
3,430
New
246
Increased
1,548
Reduced
1,426
Closed
128

Sector Composition

Rank Sector Weight
1 Technology 10.99%
2 Financials 5.01%
3 Consumer Discretionary 4.04%
4 Healthcare 3.7%
5 Industrials 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XDJL
3401
DELISTED
Innovator US Equity Accelerated ETF July
XDJL
-11,070
Closed -$332K
XDOC
3402
DELISTED
Innovator US Equity Accelerated ETF October
XDOC
-11,847
Closed -$323K
Z icon
3403
Zillow
Z
$7.48B
-4,687
Closed -$271K
XDAP
3404
DELISTED
Innovator U.S. Equity Accelerated ETF - April
XDAP
-10,318
Closed -$317K
BMTX.WS
3405
DELISTED
BM Technologies, Inc. Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50
BMTX.WS
$0 ﹤0.01%
24,304
SMAR
3406
DELISTED
Smartsheet Inc.
SMAR
-4,358
Closed -$208K
AGR
3407
DELISTED
Avangrid, Inc.
AGR
-11,222
Closed -$364K
NVEI
3408
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
-27,262
Closed -$716K
ME
3409
DELISTED
23andMe Holding Co
ME
-3,914
Closed -$72K
EGIO
3410
DELISTED
Edgio, Inc. Common Stock
EGIO
-340
Closed -$5K
ASXC
3411
DELISTED
Asensus Surgical, Inc.
ASXC
-10,075
Closed -$3K
SPWR
3412
DELISTED
SunPower Corporation Common Stock
SPWR
-10,757
Closed -$52K
OMIC
3413
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
-878
Closed -$12K
AEL
3414
DELISTED
American Equity Investment Life Holding Company
AEL
-17,952
Closed -$1M
IRBA
3415
DELISTED
iMGP RBA Responsible Global Allocation ETF
IRBA
-422,318
Closed -$3.97M
GMDA
3416
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
-72,575
Closed -$30K
SOLO
3417
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
-17,288
Closed -$6K
FSR
3418
DELISTED
Fisker Inc.
FSR
-96,044
Closed -$168K
CBAY
3419
DELISTED
Cymabay Therapeutics
CBAY
-10,533
Closed -$249K
SPLK
3420
DELISTED
Splunk Inc
SPLK
-8,763
Closed -$1.33M
BKCC
3421
DELISTED
BlackRock Capital Investment Corporation
BKCC
-14,480
Closed -$56K
BFX
3422
DELISTED
BowFlex Inc.
BFX
-25,899
Closed -$20K
NVTA
3423
DELISTED
Invitae Corporation
NVTA
-59,489
Closed -$37K
SRC
3424
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
-13,640
Closed -$596K
BETS
3425
DELISTED
Bit Brother Limited Class A Ordinary Shares
BETS
-2,000
Closed -$21K

Similar funds

Cambridge Investment Research Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Cambridge Investment Research Advisors held 3,430 positions worth $26B, up 11% from $23.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors's Q1 2024 filing shows 246 new, 1,548 increased, 1,426 reduced and 128 closed positions. Its largest new stake was Polen Capital International Growth ETF: 1,886,311 shares worth $18.9M. The largest sale was Apple, an estimated $25M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q1 2024 buy was Polen Capital International Growth ETF: 1,886,311 shares worth $18.9M.
  • Cambridge Investment Research Advisors added most to Vanguard Total Bond Market in Q1 2024, an estimated $25.4M increase.
  • Cambridge Investment Research Advisors's biggest Q1 2024 reduction was Apple, cutting an estimated $25M.
  • Cambridge Investment Research Advisors fully exited iMGP RBA Responsible Global Allocation ETF in Q1 2024, selling an estimated $3.97M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $26B portfolio in Q1 2024.
  • Cambridge Investment Research Advisors opened 246 new positions and closed 128 in Q1 2024.
  • Cambridge Investment Research Advisors's portfolio value rose 11% quarter-over-quarter to $26B.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.